Nipro Corporation

Tokyo Stock Exchange:8086.T

Sector

🏥 Health Care

Industries

💊 Drugstores & Retail Pharmacies

🧬 Biotechnology

🏥 Hospitals & Clinics

🩺 Medical Instruments

💊 Pharmaceuticals

Location

Japan

Market Cap

USD 1.41 B

Share Price

USD 8.66

Avg Daily Volume

551,372

Change (1 day)

0.07%

Change (1 year)

12.06%

Change (YTD)

-9.21%

Nipro Corporation Operating Cash Flow for the year ending March 31, 2025: USD 456.36 M

Nipro Corporation Operating Cash Flow is USD 456.36 M for the year ending March 31, 2025, a -5.30% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Nipro Corporation Operating Cash Flow for the year ending March 31, 2024 was USD 481.89 M, a 515.89% change year over year.
Nipro Corporation Operating Cash Flow for the year ending March 31, 2023 was USD 78.24 M, a -86.04% change year over year.
Nipro Corporation Operating Cash Flow for the year ending March 31, 2022 was USD 560.38 M, a -6.11% change year over year.
Nipro Corporation Operating Cash Flow for the year ending March 31, 2021 was USD 596.82 M, a 72.32% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Operating Cash Flow	Capital Expenditure	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Tokyo Stock Exchange: 8086.T

Nipro Corporation

CEO	Mr. Yoshihiko Sano
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	3-9-3 Honjo-nishi
Employees	38,117
Sector	🏥 Health Care
Industries Drugstores & Retail Pharmacies 🧬 Biotechnology 🏥 Hospitals & Clinics 🩺 Medical Instruments 💊 Pharmaceuticals

Description

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations. The company's Pharma Packaging business offers glass vials, ampoules, syringes, and cartridges; glass tubes; glass forming machinery; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.